|
Evaluation of CG-100 Intraluminal Bypass Device
RECRUITINGN/ASponsored by Colospan Ltd.
Actively Recruiting
PhaseN/A
SponsorColospan Ltd.
Started2023-03-15
Est. completion2024-06-15
Eligibility
Age22 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05632744
Summary
Evaluation of CG-100 Intraluminal Bypass device
Eligibility
Age: 22 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria (pre-operative): 1. Willing to comply with protocol-specified follow-up evaluations 2. 22-75 (inclusive) years of age at screening 3. Diagnosed with colorectal cancer 4. Has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent
Conditions2
CancerColorectal Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorColospan Ltd.
Started2023-03-15
Est. completion2024-06-15
Eligibility
Age22 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05632744